QHSLab, Inc.

QHSLab, Inc. is a medical device technology and software-as-a-service (SaaS) company that offers tools for evaluating and treating chronic diseases and providing preventive care through reimbursable procedures. The company emphasizes value-based healthcare, informatics, and algorithmic personalized medicine. Its offerings include digital therapeutics, behavior-based remote patient monitoring, and solutions for chronic and preventive care. QHSLab, Inc.'s digital healthcare, clinical decision support, and point-of-care solutions also facilitate non-face-to-face remote patient and therapeutic monitoring, addressing chronic care and preventive medicine needs. Key products include the quality health system lab expert system (QHSLab), which integrates into existing medical practice workflows to support structured screening, automated documentation, and digital follow-up, aiming to minimize disruption for physicians and staff. Another product is AllergiEnd, a diagnostic and allergen immunotherapy system designed for non-allergists in primary care settings. The company's products are developed to promote the prevention, early detection, management, and reversal of chronic diseases. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida. The company changed its name from USA Equities Corp. to QHSLab, Inc. in April 2022.